Abstract
Summary
Oxycodoneis an opioid medication. It comes in tablet shape or liquid formation. It is used for the treatment of moderate to severe pain.
The global market for Oxycodone Drug was estimated to be worth US$ 2255 million in 2023 and is forecast to a readjusted size of US$ 3480.1 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oxycodone Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oxycodone Drug by region & country, by Type, and by Application.
The Oxycodone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone Drug.
Market Segmentation
By Company
Purdue Pharma L.P
Janssen Pharmaceuticals(Johnson & Johnson)
Hikma Pharmaceuticals USA
Pfizer
Sanofi-Aventis S.A.
Sun Pharmaceutical Industries Ltd.
Oxynorm
OxyContin
Endone
Proladone
Targin
Segment by Type:
Pain Management
Anesthesia
Others
Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oxycodone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oxycodone Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Oxycodone Drug was estimated to be worth US$ 2255 million in 2023 and is forecast to a readjusted size of US$ 3480.1 million by 2030 with a CAGR of 6.5% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oxycodone Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oxycodone Drug by region & country, by Type, and by Application.
The Oxycodone Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone Drug.
Market Segmentation
By Company
Purdue Pharma L.P
Janssen Pharmaceuticals(Johnson & Johnson)
Hikma Pharmaceuticals USA
Pfizer
Sanofi-Aventis S.A.
Sun Pharmaceutical Industries Ltd.
Oxynorm
OxyContin
Endone
Proladone
Targin
Segment by Type:
Pain Management
Anesthesia
Others
Segment by Application
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oxycodone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oxycodone Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Oxycodone Drug Product Introduction
1.2 Global Oxycodone Drug Market Size Forecast
1.2.1 Global Oxycodone Drug Sales Value (2019-2030)
1.2.2 Global Oxycodone Drug Sales Volume (2019-2030)
1.2.3 Global Oxycodone Drug Sales Price (2019-2030)
1.3 Oxycodone Drug Market Trends & Drivers
1.3.1 Oxycodone Drug Industry Trends
1.3.2 Oxycodone Drug Market Drivers & Opportunity
1.3.3 Oxycodone Drug Market Challenges
1.3.4 Oxycodone Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oxycodone Drug Players Revenue Ranking (2023)
2.2 Global Oxycodone Drug Revenue by Company (2019-2024)
2.3 Global Oxycodone Drug Players Sales Volume Ranking (2023)
2.4 Global Oxycodone Drug Sales Volume by Company Players (2019-2024)
2.5 Global Oxycodone Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Oxycodone Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Oxycodone Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Oxycodone Drug
2.9 Oxycodone Drug Market Competitive Analysis
2.9.1 Oxycodone Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Oxycodone Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxycodone Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pain Management
3.1.2 Anesthesia
3.1.3 Others
3.2 Global Oxycodone Drug Sales Value by Type
3.2.1 Global Oxycodone Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oxycodone Drug Sales Value, by Type (2019-2030)
3.2.3 Global Oxycodone Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Oxycodone Drug Sales Volume by Type
3.3.1 Global Oxycodone Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Oxycodone Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Oxycodone Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Oxycodone Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals & Clinics
4.1.2 Ambulatory Surgical Centers (ASCs)
4.2 Global Oxycodone Drug Sales Value by Application
4.2.1 Global Oxycodone Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oxycodone Drug Sales Value, by Application (2019-2030)
4.2.3 Global Oxycodone Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Oxycodone Drug Sales Volume by Application
4.3.1 Global Oxycodone Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Oxycodone Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Oxycodone Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Oxycodone Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Oxycodone Drug Sales Value by Region
5.1.1 Global Oxycodone Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oxycodone Drug Sales Value by Region (2019-2024)
5.1.3 Global Oxycodone Drug Sales Value by Region (2025-2030)
5.1.4 Global Oxycodone Drug Sales Value by Region (%), (2019-2030)
5.2 Global Oxycodone Drug Sales Volume by Region
5.2.1 Global Oxycodone Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Oxycodone Drug Sales Volume by Region (2019-2024)
5.2.3 Global Oxycodone Drug Sales Volume by Region (2025-2030)
5.2.4 Global Oxycodone Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Oxycodone Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Oxycodone Drug Sales Value, 2019-2030
5.4.2 North America Oxycodone Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Oxycodone Drug Sales Value, 2019-2030
5.5.2 Europe Oxycodone Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Oxycodone Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Oxycodone Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Oxycodone Drug Sales Value, 2019-2030
5.7.2 South America Oxycodone Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oxycodone Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Oxycodone Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oxycodone Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oxycodone Drug Sales Value
6.2.1 Key Countries/Regions Oxycodone Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Oxycodone Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Oxycodone Drug Sales Value, 2019-2030
6.3.2 United States Oxycodone Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oxycodone Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oxycodone Drug Sales Value, 2019-2030
6.4.2 Europe Oxycodone Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oxycodone Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oxycodone Drug Sales Value, 2019-2030
6.5.2 China Oxycodone Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oxycodone Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oxycodone Drug Sales Value, 2019-2030
6.6.2 Japan Oxycodone Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oxycodone Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oxycodone Drug Sales Value, 2019-2030
6.7.2 South Korea Oxycodone Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oxycodone Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oxycodone Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Oxycodone Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oxycodone Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oxycodone Drug Sales Value, 2019-2030
6.9.2 India Oxycodone Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oxycodone Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Purdue Pharma L.P
7.1.1 Purdue Pharma L.P Company Information
7.1.2 Purdue Pharma L.P Introduction and Business Overview
7.1.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Purdue Pharma L.P Oxycodone Drug Product Offerings
7.1.5 Purdue Pharma L.P Recent Development
7.2 Janssen Pharmaceuticals(Johnson & Johnson)
7.2.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
7.2.2 Janssen Pharmaceuticals(Johnson & Johnson) Introduction and Business Overview
7.2.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Offerings
7.2.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Development
7.3 Hikma Pharmaceuticals USA
7.3.1 Hikma Pharmaceuticals USA Company Information
7.3.2 Hikma Pharmaceuticals USA Introduction and Business Overview
7.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Offerings
7.3.5 Hikma Pharmaceuticals USA Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Oxycodone Drug Product Offerings
7.4.5 Pfizer Recent Development
7.5 Sanofi-Aventis S.A.
7.5.1 Sanofi-Aventis S.A. Company Information
7.5.2 Sanofi-Aventis S.A. Introduction and Business Overview
7.5.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sanofi-Aventis S.A. Oxycodone Drug Product Offerings
7.5.5 Sanofi-Aventis S.A. Recent Development
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Company Information
7.6.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.6.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Offerings
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.7 Oxynorm
7.7.1 Oxynorm Company Information
7.7.2 Oxynorm Introduction and Business Overview
7.7.3 Oxynorm Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Oxynorm Oxycodone Drug Product Offerings
7.7.5 Oxynorm Recent Development
7.8 OxyContin
7.8.1 OxyContin Company Information
7.8.2 OxyContin Introduction and Business Overview
7.8.3 OxyContin Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 OxyContin Oxycodone Drug Product Offerings
7.8.5 OxyContin Recent Development
7.9 Endone
7.9.1 Endone Company Information
7.9.2 Endone Introduction and Business Overview
7.9.3 Endone Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Endone Oxycodone Drug Product Offerings
7.9.5 Endone Recent Development
7.10 Proladone
7.10.1 Proladone Company Information
7.10.2 Proladone Introduction and Business Overview
7.10.3 Proladone Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Proladone Oxycodone Drug Product Offerings
7.10.5 Proladone Recent Development
7.11 Targin
7.11.1 Targin Company Information
7.11.2 Targin Introduction and Business Overview
7.11.3 Targin Oxycodone Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Targin Oxycodone Drug Product Offerings
7.11.5 Targin Recent Development
8 Industry Chain Analysis
8.1 Oxycodone Drug Industrial Chain
8.2 Oxycodone Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oxycodone Drug Sales Model
8.5.2 Sales Channel
8.5.3 Oxycodone Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer